Getinge posts 17.6% adjusted EBITA margin in Q2 2026

Medical technology group kept its 2026 organic sales growth forecast of 3%-5% after reporting stronger profitability, cash flow and a SEK 336 million tariff refund in the April-June period.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.